Gottit. Thanks.
- Forums
- ASX - By Stock
- PAR
- NGF - and why the competition doesn't work
PAR
paradigm biopharmaceuticals limited..
Add to My Watchlist
3.23%
!
45.0¢

NGF - and why the competition doesn't work, page-6
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
45.0¢ |
Change
-0.015(3.23%) |
Mkt cap ! $184.8M |
Open | High | Low | Value | Volume |
47.0¢ | 47.5¢ | 43.0¢ | $166.7K | 366.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 65136 | 45.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
45.5¢ | 4000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 65136 | 0.450 |
1 | 8166 | 0.440 |
3 | 17372 | 0.435 |
3 | 102031 | 0.430 |
4 | 161397 | 0.425 |
Price($) | Vol. | No. |
---|---|---|
0.455 | 4000 | 1 |
0.460 | 7804 | 2 |
0.465 | 2139 | 1 |
0.470 | 36842 | 3 |
0.475 | 33376 | 3 |
Last trade - 10.35am 07/07/2025 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online